US Patent Issued to University of Rochester on Sept. 23 for "Anti-influenza neuraminidase monoclonal antibodies and uses thereof" (New York Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,421,301, issued on Sept. 23, was assigned to University of Rochester (Rochester, N.Y.).

"Anti-influenza neuraminidase monoclonal antibodies and uses thereof" was invented by James J. Kobie (Rochester, N.Y.), Luis Martinez-Sobrido (Rochester, N.Y.), Michael Piepenbrink (Rochester, N.Y.) and Aitor Nogales (Rochester, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to broadly neutralizing anti-influenza monoclonal antibodies or antigen-binding fragments thereof. The present invention further relates to therapeutic uses of the isolated antibody or the antigen-binding fragment thereof."

The patent was filed on March 5, 202...